SNX3 exacerbates hepatic fibrosis by amplifying TGF-β1/Smad signaling pathway in hepatocyte-HSC fibrotic loop.
- DOI
- 10.1016/j.apsb.2026.06.021
- Published
- 2026 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.06.021,
title = {SNX3 exacerbates hepatic fibrosis by amplifying TGF-β1/Smad signaling pathway in hepatocyte-HSC fibrotic loop.},
author = {Zhang J and Dai Y and Yu J and Chen Y and Ma D and Yu W and Peng M and Li Z and Lu J and Xu H and Xu S and Sun D and Liu P},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2026.06.021},
url = {https://doi.org/10.1016/j.apsb.2026.06.021}
}RIS
TY - JOUR TI - SNX3 exacerbates hepatic fibrosis by amplifying TGF-β1/Smad signaling pathway in hepatocyte-HSC fibrotic loop. AU - Zhang J AU - Dai Y AU - Yu J AU - Chen Y AU - Ma D AU - Yu W AU - Peng M AU - Li Z AU - Lu J AU - Xu H AU - Xu S AU - Sun D AU - Liu P PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2026.06.021 UR - https://doi.org/10.1016/j.apsb.2026.06.021 ER -
APA
J, Z., Y, D., J, Y., Y, C., D, M., W, Y., M, P., Z, L., J, L., H, X., S, X., D, S., & P, L. (2026). SNX3 exacerbates hepatic fibrosis by amplifying TGF-β1/Smad signaling pathway in hepatocyte-HSC fibrotic loop.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.06.021
Source records
- pubmed · retrieved 2026-09-26T13:44:42.405Z